Page last updated: 2024-10-27

gabexate and Infection

gabexate has been researched along with Infection in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC."9.06Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988)
"The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC."5.06Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Umeki, S1
Adachi, M1
Watanabe, M1
Yaji, S1
Soejima, R1

Trials

1 trial available for gabexate and Infection

ArticleYear
Gabexate as a therapy for disseminated intravascular coagulation.
    Archives of internal medicine, 1988, Volume: 148, Issue:6

    Topics: Anticoagulants; Clinical Trials as Topic; Disseminated Intravascular Coagulation; Gabexate; Guanidin

1988